What does APOTHEEK BROECHOVEN do?

APOTHEEK BROECHOVEN is a pharmacy in Ternat. Public Limited, started on 24 December 1996, 1 establishment.

What is the address of APOTHEEK BROECHOVEN?

The registered office of APOTHEEK BROECHOVEN is located at Kerkstraat 14, 1742 Ternat.

Is APOTHEEK BROECHOVEN still active?

Yes. According to the CBE (29 October 2026) APOTHEEK BROECHOVEN is active, legal situation “Normale toestand”, started on 24 December 1996.

Is APOTHEEK BROECHOVEN registered on Peppol?

Yes, APOTHEEK BROECHOVEN is registered on the Peppol network with ID 0208:0459570162.

What is the enterprise number of APOTHEEK BROECHOVEN?

The enterprise number of APOTHEEK BROECHOVEN is BE0459570162.

When was APOTHEEK BROECHOVEN founded?

APOTHEEK BROECHOVEN was founded on 24 December 1996.

Who are the directors of APOTHEEK BROECHOVEN?

According to the 2025 annual accounts, the directors of APOTHEEK BROECHOVEN are: Karipharma BV.

Is APOTHEEK BROECHOVEN a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 24 December 1996; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did APOTHEEK BROECHOVEN make in 2025?

APOTHEEK BROECHOVEN posted a profit after taxes of € 37,246 in financial year 2025.

What is the revenue of APOTHEEK BROECHOVEN?

As a small company, APOTHEEK BROECHOVEN is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 308,757.

How much does an employee at APOTHEEK BROECHOVEN earn?

The average wage cost per full-time employee at APOTHEEK BROECHOVEN was € 71,000 in 2025: staff costs of € 255,556 for 3.6 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does APOTHEEK BROECHOVEN have?

According to the 2025 annual accounts, APOTHEEK BROECHOVEN has 3.6 full-time equivalents (FTE).

APOTHEEK BROECHOVEN (Public Limited) - Ternat

Dossier APOTHEEK BROECHOVEN, printed on 29 October 2026 from databakkes.be/en/0459570162/apotheek-broechoven. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

APOTHEEK BROECHOVEN from Ternat, company number BE0459570162, closed financial year 2025 with a result of € 37,246 after tax. For that financial year APOTHEEK BROECHOVEN recorded a gross margin of € 308,757 and equity of € 478,279. Compared with financial year 2024, the result moved from € 147,531 to € 37,246. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 17, 2026.

What it is worth Growing

€ 478,279

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 37,246

▼ 75% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 221,776

▼ 10% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 35,000 paid out

94 % of the profit went to the shareholders, mostly to KARIPHARMA (100 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

3.6

▲ 0.6 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 255,556

▲ 48% vs 2024

€ 71,000 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 295,220

▼ 11% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Wages and social charges

€ 29,662

▲ 46% vs 2024

Wages, holiday pay and social contributions still to pay. No outstanding taxes.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 331,354 Gross margin 2022: € 331,354 First fiscal year in the series	€ 252,347 Gross margin 2023: € 252,347 ▼ 24% vs 2022 (€ 331,354) Unfavourable step	€ 367,132 Gross margin 2024: € 367,132 ▲ 45% vs 2023 (€ 252,347) Favourable step	€ 308,757 Gross margin 2025: € 308,757 ▼ 16% vs 2024 (€ 367,132) Unfavourable step	▼ 16%
Profit after taxes	€ 32,613 Profit after taxes 2022: € 32,613 First fiscal year in the series	€ 4,501 Profit after taxes 2023: € 4,501 ▼ 86% vs 2022 (€ 32,613) Unfavourable step	€ 147,531 Profit after taxes 2024: € 147,531 ▲ € 143,029 vs 2023 (€ 4,501) Favourable step	€ 37,246 Profit after taxes 2025: € 37,246 ▼ 75% vs 2024 (€ 147,531) Unfavourable step	▼ 75%
Equity	€ 464,001 Equity 2022: € 464,001 First fiscal year in the series	€ 468,502 Equity 2023: € 468,502 ▲ 1% vs 2022 (€ 464,001) Favourable step	€ 476,033 Equity 2024: € 476,033 ▲ 2% vs 2023 (€ 468,502) Favourable step	€ 478,279 Equity 2025: € 478,279 Unchanged (€ 476,033) Favourable step
Total debts	€ 646,739 Total debts 2022: € 646,739 First fiscal year in the series	€ 453,585 Total debts 2023: € 453,585 ▼ 30% vs 2022 (€ 646,739) Favourable step	€ 504,328 Total debts 2024: € 504,328 ▲ 11% vs 2023 (€ 453,585) Unfavourable step	€ 384,983 Total debts 2025: € 384,983 ▼ 24% vs 2024 (€ 504,328) Favourable step	▼ 24%
Cash	€ 259,786 Cash 2022: € 259,786 First fiscal year in the series	€ 253,219 Cash 2023: € 253,219 ▼ 3% vs 2022 (€ 259,786) Unfavourable step	€ 245,355 Cash 2024: € 245,355 ▼ 3% vs 2023 (€ 253,219) Unfavourable step	€ 221,776 Cash 2025: € 221,776 ▼ 10% vs 2024 (€ 245,355) Unfavourable step	▼ 10%
Retained profit	€ 402,028 Retained profit 2022: € 402,028 First fiscal year in the series	€ 406,529 Retained profit 2023: € 406,529 ▲ 1% vs 2022 (€ 402,028) Favourable step	€ 414,060 Retained profit 2024: € 414,060 ▲ 2% vs 2023 (€ 406,529) Favourable step	€ 416,306 Retained profit 2025: € 416,306 ▲ 1% vs 2024 (€ 414,060) Favourable step	▲ 1%
Dividend	€ 15,000 Dividend 2022: € 15,000 First fiscal year in the series	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 15,000) Unchanged	€ 140,000 Dividend 2024: € 140,000 Unchanged (€ 0) Unchanged	€ 35,000 Dividend 2025: € 35,000 ▼ 75% vs 2024 (€ 140,000) Unchanged	▼ 75%
Bank debt	€ 94,615 Bank debt 2022: € 94,615 First fiscal year in the series	€ 54,530 Bank debt 2023: € 54,530 ▼ 42% vs 2022 (€ 94,615) Favourable step	€ 13,751 Bank debt 2024: € 13,751 ▼ 75% vs 2023 (€ 54,530) Favourable step	€ 0 Bank debt 2025: € 0 ▼ 100% vs 2024 (€ 13,751) Favourable step	▼ 100%
Balance sheet total	€ 1,110,740 Balance sheet total 2022: € 1,110,740 First fiscal year in the series	€ 922,087 Balance sheet total 2023: € 922,087 ▼ 17% vs 2022 (€ 1,110,740) Unchanged	€ 980,361 Balance sheet total 2024: € 980,361 ▲ 6% vs 2023 (€ 922,087) Unchanged	€ 863,262 Balance sheet total 2025: € 863,262 ▼ 12% vs 2024 (€ 980,361) Unchanged	▼ 12%
Employees (FTE)	3.9 Employees (FTE) 2022: 3.9 First fiscal year in the series	3.2 Employees (FTE) 2023: 3.2 ▼ 0.7 vs 2022 (3.9) Unchanged	3 Employees (FTE) 2024: 3 ▼ 0.2 vs 2023 (3.2) Unchanged	3.6 Employees (FTE) 2025: 3.6 ▲ 0.6 vs 2024 (3) Unchanged	▲ 0.6

Key figures of APOTHEEK BROECHOVEN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APOTHEEK BROECHOVEN?

What happened at APOTHEEK BROECHOVEN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2030 Karipharma BV stepped down as director. NBB
Jun 17, 2026 New annual accounts for financial year 2025: profit of € 37,246 (▼ 75% vs 2024). Source: NBB ↗
2024 Karipharma BV became a director. NBB
Apr 24, 1997 New establishment in Ternat. KBO
Dec 24, 1996 Start of the company according to the CBE. KBO

In short

From € 32,613 profit in 2022 to € 37,246 profit in 2025.

Paid € 15,000 in corporate taxes since 2022.

Best year ever: 2024, with € 147,531 profit.

On average € 85,800 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

KARIPHARMA 100%

The stake of KARIPHARMA comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

APOTHEEK BROECHOVEN

The shares are held by KARIPHARMA (100%).

Directors

According to the 2025 annual accounts

Karipharma BV

Director · represented by Broechoven Kristel

since 2024 · until 2030

Shareholders

KARIPHARMA

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Kerkstraat 14

1742 Ternat

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

KARIPHARMA same network

€ 129,534 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0459.570.162

VAT number

BE 0459.570.162

Registered office

Kerkstraat 14, 1742 Ternat

Names & denominations

APOTHEEK BROECHOVEN

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

24 December 1996

Peppol

Active · Active since 17 Mar 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTHEEK BROECHOVEN

Financials

What happened to APOTHEEK BROECHOVEN?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions